522.A1. Analyst Report : Akili's Emdeavor OTC & RX
About Akili (company's description):
Akili is pioneering the development of cognitive treatments through game-changing technologies. Akili’s approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device, but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com
Types of Offerings. The two current flagship products are listed below:
Introducing EndeavorOTC™ - a game-based treatment clinically proven to improve attention and focus, specifically in adults with ADHD!
EndeavorRx® for children with ADHD - the first FDA-authorized prescription video game treatment
The team
Leadership team
